Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

被引：135

作者：

Zhou, Jian

Sun, Huichuan

Wang, Zheng

Cong, Wenming

Zeng, Mengsu

Zhou, Weiping

Bie, Ping

Liu, Lianxin

Wen, Tianfu

Kuang, Ming

Han, Guohong

Yan, ZhiPing

Wang, Maoqiang

Liu, Ruibao

Lu, Ligong

Ren, Zhenggang

Zeng, ZhaoChong

Liang, Ping

Liang, Changhong

Chen, Min

Yan, Fuhua

Wang, Wenping

Hou, Jinlin

Ji, Yuan

Yun, Jingping

Bai, Xueli

Cai, Dingfang

Chen, Weixia

Chen, Yongjun

Cheng, Wenwu

Cheng, Shuqun

Dai, Chaoliu

Guo, Wenzhi

Guo, Yabing

Hua, Baojin

Huang, Xiaowu

Jia, Weidong

Li, Qiu

Li, Tao

Li, Xun

Li, Yaming

Li, Yexiong

Liang, Jun

Ling, Changquan

Liu, Tianshu

Liu, Xiufeng

Lu, Shichun

Lv, Guoyue

Mao, Yilei

Meng, Zhiqiang

机构：

[1] Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai

[2] Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai

[3] Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai

[4] Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang

[5] Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai

[6] Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou

[7] The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai

[8] Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou

[9] Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing

[10] Graduate School, Beijing University of Chinese Medicine, Beijing

[11] Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin

[12] Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei

[13] Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu

[14] Department of Oncology, West China Hospital, Sichuan University, Chengdu

[15] Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou

[16] Department of General Surgery, Qilu Hospital, Shandong University, Jinan

[17] Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an

[18] The First Hospital of Lanzhou University, Lanzhou

[19] Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai

[20] Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang

[21] Department of Interventional Radiology, Chinese PLA General Hospital, Beijing

[22] Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

[23] Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin

[24] Department of Oncology, Peking University International Hospital, Beijing

[25] Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

[26] Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai

[27] Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai

[28] Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai

[29] Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing

[30] Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing

[31] Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

[32] Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing

[33] Editorial Department of Chinese Journal of Digestive Surgery, Chongqing

[34] Department of General Surgery, The First Hospital of Jilin University, Jilin

[35] Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

[36] Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing

[37] Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai

[38] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai

[39] Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital Southern Medical University, Guangzhou

[40] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning

[41] Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai

[42] Department of Interventional Radiology the First Affiliated Hospital of Xinjiang Medical University, Urumqi

[43] Department of Pathology, Tumor Prevention and Treatment Center, Sun Yat-sen University, Guangzhou

[44] Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai

[45] Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou

[46] Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin

[47] Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai

[48] Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an

[49] Department of Radiology, West China Hospital of Sichuan University, Chengdu

[50] Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai

来源：

LIVER CANCER | 2023年 / 12卷 / 05期

关键词：

Primary liver cancer; hepatocellular carcinoma; guidelines; China; diagnosis; treatment; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONTRAST-ENHANCED ULTRASOUND; RANDOMIZED CONTROLLED-TRIAL; STEREOTACTIC BODY RADIOTHERAPY; PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION; SIROLIMUS-BASED IMMUNOSUPPRESSION; VS. RADIOFREQUENCY ABLATION; SURGICAL RESECTION; OPEN-LABEL;

D O I：

10.1159/000530495

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Primary liver cancer, around 75%-85% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China, but also may re-shape the nationwide diagnosis and treatment of liver cancer. Key Messages: The new guideline aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."

引用

页码：405 / 444

页数：40

共 50 条

[31] Guidelines for diagnosis and treatment of primary aldosteronism
Januszewicz, Andrzej
Kokot, Franciszek
Widecka, Krystyna
Wiecek, Andrzej
Czekalski, Stanislaw
Cieszanowski, Andrzej
Ciechanowicz, Andrzej
Chudek, Jerzy
Dobrucki, Tomasz
Florczak, Elibieta
Gaciong, Zbigniew
Gluszek, Jerzy
Grodzicki, Tomasz
Janaszek-Sitkowska, Hanna
Januszewicz, Magdalena
Januszewicz, Wlodzimierz
Kabat, Marek
Kasperlik-Zaluska, Anna
Krolicki, Leszek
Litwin, Mieczyslaw
Makowiecka-Ciesla, Magdalena
Narkiewicz, Krzysztof
Otto, Maciej
Prejbisz, Aleksander
Romer, Tomasz
Sznajderman, Marek
Tykarski, Andrzej
Walecki, Jerzy M.
Wasiutynski, Aleksander
Zgliczynski, Wojciech
ARTERIAL HYPERTENSION, 2008, 12 (03): : 155 - 168
[32] Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version)
Zhi, Xiu-Yi
Yu, Jin-Ming
Shi, Yuan-Kai
CANCER, 2015, 121 : 3165 - 3181
[33] Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Guo, Jun
Qin, Shukui
Liang, Jun
Lin, Tongyu
Si, Lu
Chen, Xiaohong
Chi, Zhihong
Cui, Chuanliang
Du, Nan
Fan, Yun
Gu, Kangsheng
Li, Fang
Li, Junling
Li, Yongheng
Liang, Houjie
Liu, Jiwei
Lu, Man
Lu, Aiping
Nan, Kejun
Niu, Xiaohui
Pan, Hongming
Ren, Guoxin
Ren, Xiubao
Shu, Yongqian
Song, Xin
Tao, Min
Wang, Baocheng
Wei, Wenbin
Wu, Di
Wu, Lingying
Wu, Aiwen
Xu, Xiaolin
Zhang, Junyi
Zhang, Xiaoshi
Zhang, Yiping
Zhu, Huiyan
ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (21)
[34] Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)
Guo, Jun
Qin, Shukui
Liang, Jun
Lin, Tongyu
Si, Lu
Chen, Xiaohong
Chi, Zhihong
Cui, Chuanliang
Du, Nan
Fan, Yun
Gu, Kangsheng
Li, Fang
Li, Junling
Li, Yongheng
Liang, Houjie
Liu, Jiwei
Lu, Man
Lu, Aiping
Nan, Kejun
Niu, Xiaohui
Pan, Hongming
Ren, Guoxin
Ren, Xiubao
Shu, Yongqian
Song, Xin
Tao, Min
Wang, Baocheng
Wei, Wenbin
Wu, Di
Wu, Lingying
Wu, Aiwen
Xu, Xiaolin
Zhang, Junyi
Zhang, Xiaoshi
Zhang, Yiping
Zhu, Huiyan
CHINESE CLINICAL ONCOLOGY, 2016, 5 (04)
[35] Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Zhou, Jian
Sun, Huichuan
Wang, Zheng
Cong, Wenming
Wang, Jianhua
Zeng, Mengsu
Zhou, Weiping
Bie, Ping
Liu, Lianxin
Wen, Tianfu
Han, Guohong
Wang, Maoqiang
Liu, Ruibao
Lu, Ligong
Ren, Zhengang
Chen, Minshan
Zeng, Zhaochong
Liang, Ping
Liang, Changhong
Chen, Min
Yan, Fuhua
Wang, Wenping
Ji, Yuan
Yun, Jingping
Cai, Dingfang
Chen, Yongjun
Cheng, Wenwu
Cheng, Shuqun
Dai, Chaoliu
Guo, Wenzhi
Hua, Baojin
Huang, Xiaowu
Jia, Weidong
Li, Yaming
Li, Yexiong
Liang, Jun
Liu, Tianshu
Lv, Guoyue
Mao, Yilei
Peng, Tao
Ren, Weixin
Shi, Hongcheng
Shi, Guoming
Tao, Kaishan
Wang, Wentao
Wang, Xiaoying
Wang, Zhiming
Xiang, Bangde
Xing, Baocai
Xu, Jianming
LIVER CANCER, 2020, 9 (06) : 682 - 720
[36] Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)
Zhang, Zhiyi
Huang, Cibo
Jiang, Quan
Zheng, Yi
Liu, Yi
Liu, Shengyun
Chen, Yingjuan
Mei, Yifang
Ding, Changhai
Chen, Min
Gu, Xin
Xing, Dan
Gao, Min
He, Lan
Ye, Zhizhong
Wu, Lijun
Xu, Jianhua
Yang, Pinting
Zhang, Xuewu
Zhang, Yue
Chen, Jinwei
Lin, Jin
Zhao, Like
Li, Mengtao
Yang, Wanling
Zhou, Yixin
Jiang, Qing
Chu, Cong-Qiu
Chen, Yaolong
Zhang, Weiya
Tsai, Wei-Chung
Lei, Guanghua
He, Dongyi
Liu, Wei
Fang, Yongfei
Wu, Darong
Lin, Jianhao
Wei, Cheng-Chung
Lin, Hsiao-Yi
Zeng, Xiaofeng
ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (19)
[37] Chinese quality control indices for standardized diagnosis and treatment of gastric cancer (2022 edition)
Li, Shen
Shan, Fei
Zhang, Xiaotian
Li, Yongheng
Sun, Yu
Tang, Lei
Wu, Qi
Yang, Wenjing
Yang, Jincheng
An, Yu
Deng, Ming
Ji, Jiafu
CHINESE JOURNAL OF CANCER RESEARCH, 2022, 34 (06) : 623 - 632
[38] Chinese quality control indices for standardized diagnosis and treatment of renal cancer (2022 edition)
Yao, Lin
Du, Yicong
Dong, Wen
Gao, Xianshu
Guo, Jun
Qiu, Jianxing
Wei, Qiang
Wu, Shikai
Ye, Dingwei
Yu, Wei
Zeng, Hao
Zhang, Qian
Zhang, Yong
Zhang, Zhiling
Zhou, Fangjian
Yang, Wenjing
Wang, Hui
Zhang, Xu
He, Zhisong
JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (01): : 6 - 13
[39] Quality control indices for standardized diagnosis and treatment of esophageal cancer in China (2022 edition)
Zhang, Ruixiang
Wang, Zhen
Kang, Xiaozheng
Wang, Xin
Zhang, Bo
Ng, Hoi-loi
Xue, Liyan
Yang, Wenjing
Shi, Liming
Wang, Hui
Wang, Lvhua
Li, Yin
JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (03): : 167 - 174
[40] Chinese quality control indices for standardized diagnosis and treatment of gastric cancer(2022 edition)
Shen Li
Fei Shan
Xiaotian Zhang
Yongheng Li
Yu Sun
Lei Tang
Qi Wu
Wenjing Yang
Jincheng Yang
Yu An
Ming Deng
Jiafu Ji
ChineseJournalofCancerResearch, 2022, 34 (06) : 623 - 632

← 1 2 3 4 5 →